The mammalian proglucagon gene encodes three related sequences, glucagon and the glucagon-like peptides 1 and 2 
T he regulation of metabolism in vertebrate animals is both essential and complex, involving hormonal, neuronal, and behavioral responses (Schwartz et al. 2000) . Recently, a large number of genes have been identified that encode hormones with roles regulating metabolic physiology and appetite (Schwartz et al. 2000 , Sahu 2004 ). Many previously characterized hormones also have functions in the control of energy balance. The roles of most of these hormones, which probably originated in the earliest vertebrates, have been extensively studied in humans and rodents. However, scientists' understanding of the origin of this complex system is far from complete, with only a few of the elements having been examined in any detail (Leo et al. 2002) . The evolution of the vertebrate proglucagon gene, and of the genes for the receptors encoded by this gene, illustrates part of this story.
The regulation of blood glucose levels is essential in humans. Failure to properly regulate these levels because of the absence of, or inability to respond to, the hormone insulin, which stimulates cells to take up glucose from the blood, leads to diabetes (Kahn 2003) . Soon after the discovery of insulin and its central role in the regulation of metabolism, its partner glucagon, which plays an opposing role in glucose metabolism, was discovered. Glucagon is a peptide hormone composed of 29 amino acids and encoded within the proglucagon gene. It is secreted by the α cells of pancreatic islets in response to low blood glucose levels, and promotes an increase in glucose production and secretion by the liver (figure 1a; Evans and Sherwin 2003, Jiang and Zhang 2003) .
The isolation and characterization of proglucagon genes led to the discovery that the proglucagon gene encodes additional hormones. Copies of the messenger RNA (mRNA) transcript (an RNA sequence that is translated into a protein) produced by the proglucagon gene were cloned as complementary DNAs, or cDNAs (DNA copies of mRNA), and the sequences of these clones showed that the amino acid sequence of the proglucagon precursor contained two additional glucagon-like sequences, glucagon-like peptide 1 (GLP-1) and glucagon-like peptide 2 (GLP-2) (figure 1a; Kieffer and Habener 1999, Drucker 2003) .
In humans and other mammals, GLP-1 is secreted by intestinal L cells and acts as an incretin hormone (Anini and Brubaker 2003) in response to food intake to enhance the secretion of insulin (i.e., more insulin is secreted from islet cells in response to glucose that is absorbed from the gut than is secreted when glucose is injected intravenously). In the presence of both GLP-1 and elevated blood glucose levels, β cells on the pancreatic islets secrete greater amounts of insulin, whereupon the liver removes glucose from the blood, lowering blood sugar levels. GLP-1 analogs are being evaluated as potential therapies for the treatment of diabetes (Nauck and Meier 2005) .
The second glucagon-like peptide, GLP-2, also has an important role in mammalian metabolism. GLP-2 in mammals is an intestinal growth factor promoting regeneration and maintenance of intestinal epithelial cells (Anini and Brubaker 2003) .
Whereas the biological functions of the proglucagonderived peptides have been studied most extensively in mammalian species, the glucagon gene and the actions of glucagon and GLP-1 have been described also in some species of bony fish (figure 1b; Duguay and Mommsen 1994 , Plisetskaya and Mommsen 1996 , Moon 1998 . In general, the actions of glucagon as a glycogenolytic hormone (i.e., stimulating the production and secretion of glucose from the liver) are conserved in vertebrates (Duguay and Mommsen 1994 , Plisetskaya and Mommsen 1996 , Moon 1998 , Evans and Sherwin 2003 . Glucagon has been isolated and characterized from more than 50 diverse vertebrate species, and its amino acid sequence is largely conserved (Irwin 2001) . The conservation of amino acid sequence is sufficient to allow mammalian and fish glucagons to replace each other (Duguay and Mommsen, 1994 , Plisetskaya and Mommsen 1996 , Moon 1998 . In fish, in contrast to mammals, GLP-1 stimulates the production of glucose by the liver, leading to higher blood sugar levels. Thus, in fish, glucagon and GLP-1 have similar physiological actions (Duguay and Mommsen 1994 , Plisetskaya and Mommsen 1996 , Moon 1998 . GLP-1 has been characterized from more than 30 vertebrate species (Irwin 2001 from fish or mammalian sources always acts as an incretin hormone when given to mammals, but acts much like glucagon when given to fish (Duguay and Mommsen 1994 , Plisetskaya and Mommsen 1996 , Moon 1998 . These observations indicate that GLP-1 in both mammalians and fish binds and activates the same receptor, and that the difference in the physiological action of GLP-1 in fish and mammalians is due to the site of expression and the downstream signaling properties of the receptors.
Origin of proglucagon
Mammalian genomes possess six genes that encode sequences similar to the glucagon sequence (Hoyle 1998 , Sherwood et al. 2000 . Since some genes encode more than one such sequence (e.g., the proglucagon gene encodes glucagon and two glucagon-like sequences), mammals have a total of 10 hormones with similarity to glucagon. In addition to the proglucagon gene, the members of this gene family are the genes for secretin, for glucose-dependent insulinotropic peptide (GIP), and for growth hormone-releasing factor (GRF), each of which encodes a single glucagon-like sequence, and two genes that each encode two peptides, the pituitary adenylate cyclase-activating peptide (PACAP) gene (encoding PACAP and the PACAP-related peptide, PRP) and the vasoactive intestinal peptide (VIP) gene (encoding VIP and the peptide histidine isoleucine, PHI, or in some species the peptide histidine methionine, PHM). At least two more members of this gene family are also found in some vertebrate genomes. The gila monster, a reptile, possesses genes for the glucagon-like sequences exendin and helodermin, for example (Chen and Drucker 1997, Pohl and Wank 1998) . The proglucagon gene diverged from the remaining members of the glucagon gene family before or during the origin of vertebrates (Lopez et al. 1984 , Irwin et al. 1999 . Whether the divergence of the proglucagonderived peptides occurred before or after the divergence of the proglucagon gene from other members of the gene family is unclear, as are many of the interrelationships among members of the gene family (Hoyle 1998 , Sherwood et al. 2000 , Irwin 2002 , Clynen et al. 2005 . This is largely because these peptides are of ancient origin, show considerable divergence, and are extremely short (27 to 48 amino acids, with fewer than 30 shared), which makes it difficult to use them for establishing phylogenetic relationships (Dores et al. 1996) .
Genome duplications and the origin of new genes
A possible explanation for the origin of some of the genes encoding sequences similar to glucagon's is that genome duplication events generated extra copies of every gene. Genome duplications appear to have been very important in the origin and evolution of vertebrates (Hokamp et al. 2003) and have probably contributed to their complex physiological systems, including those involving glucagon. It has been hypothesized that two rounds of genome duplication (the 2R hypothesis) occurred early in the vertebrate lineage, initially generating four copies of every ancestral gene, although some of these extra genes may have subsequently been lost. Possibly the best example of the product of these two genome duplications is the four HOX gene clusters that are found in many vertebrate genomes (Kappen et al. 1989 ). The proglucagon and GIP genes are located close to HOX genes on human chromosomes 2 and 17, respectively, and possibly originated through genome duplication (Irwin 2002) . Surprisingly, fish genomes were found to have more than four HOX gene clusters, which led to the suggestion that one more genome duplication event has occurred in the fish lineage (Amores et al. 1998 , Aparicio 2000 . The availability of draft genomes for fish has largely supported this hypothesis, as a large proportion of fish genes are found as duplicates (Taylor et al. 2003) . Thus, it may be expected that fish will show more gene complexity than mammals for physiological systems.
Evolution of proglucagon
Whereas the interrelationships of genes that encode hormones similar to glucagon have been difficult to unravel, the evolution of the peptides encoded by proglucagon is better understood. The proglucagon-derived peptides glucagon, GLP-1, and GLP-2 are distinct peptide hormones but are derived from a single common ancestral sequence (Lopez et al. 1984 , Irwin et al. 1999 . We know that all three of these peptide hormones originated before the earliest divergences of vertebrates, because all three peptides are encoded by proglucagon genes in mammals, birds, reptiles, frogs, and both bony and jawless fish (Irwin et al. 1999 , Irwin 2001 . GLP-1 and GLP-2 are more closely related to each other than to glucagon, but it is unclear whether the first duplication within the proglucagon gene to generate a glucagon and glucagon-like peptide ancestor occurred before or after divergence of the remaining members of the gene family of glucagon-like sequences (Hoyle 1998 , Sherwood et al. 2000 , Irwin 2002 , Clynen et al. 2005 . Although all vertebrates that have been examined possess all three proglucagon-derived peptides, some variation in the structure of the proglucagon polypeptide precursor does occur. Multiple proglucagon genes have been found in the genomes of both teleost fish and the lamprey, a jawless fish (Lund et al. 1982 , Irwin and Wong 1995 , Irwin et al. 1999 , Zhou and Irwin 2004 . In the lamprey, although both proglucagon genes encode glucagon, one encodes GLP-1 while the other encodes a full-length GLP-2 sequence (Irwin et al. 1999) . Within the teleost fish, as well, two types of proglucagon gene exist in species with complete genome sequences (namely, zebrafish and pufferfish). The two teleost proglucagon genes are most likely products of the fishspecific genome duplication event described above (Irwin 2002, Zhou and Irwin 2004) . The first gene encodes all three proglucagon-like peptides, and is transcribed and alternatively spliced to generate two distinct but overlapping mRNAs, which encode different proglucagon precursors that can be processed to generate different sets of hormones (Irwin and Wong 1995) . Alternative splicing generates one mRNA transcript that can yield glucagon, GLP-1, and GLP-2, while the alternative mRNA transcript encodes only glucagon and GLP-1 (figure 1b). The second proglucagon gene encodes just glucagon and GLP-1 (figure 1b; Zhou and Irwin 2004) . The structure of the frog proglucagon genes differs from the standard one, and these genes encode two or three GLP-1-like peptide sequences (Irwin et al. 1997, Irwin and Sivarajah 2000) . Thus, although all vertebrates examined to date possess the hormones glucagon, GLP-1, and GLP-2, the structure of the genes that encode these hormones varies.
Not only has the structure of proglucagon genes and polypeptides varied, but so have their sequences. Within the vertebrates, the evolution of each of the three proglucagonderived peptides occurred episodically (Irwin 2001) . Glucagon and GLP-1 are well conserved and evolve slowly in species that encode only a single glucagon or GLP-1. Duplication of the proglucagon gene (e.g., in fish), or of the GLP-1 peptide within a gene (e.g., in frogs), is associated with more rapid sequence evolution. Thus, glucagon and GLP-1 in teleost fish, and GLP-1 in frogs, are evolving faster than most glucagon and GLP-1 sequences (Irwin 2001) . In general, GLP-2 evolves more rapidly than glucagon or GLP-1, but also shows an episodic pattern of evolution. GLP-2 had a period of rapid sequence evolution early in the mammalian lineage. This has been followed by a slowdown in the rate of evolution within mammals (Irwin 2001 ). Changes in rates of sequence evolution indicate changes in selective pressure on the sequences, and often identify a period when a change in the function of a sequence has occurred. For example, the evolution of stomach lysozymes as digestive enzymes in ruminant artiodactyls and leaf-eating monkeys involved a period of rapid adaptive sequence evolution (Irwin et al. 1992, Messier and Stewart 1997) .
Receptors for proglucagon-derived peptides
Hormones typically mediate their physiological effects through interaction with specific receptor molecules located on the surface of cells in the target tissue. The binding of a hormone to a receptor results in a signal being transmitted into the cell, which can lead to changes in cell physiology (e.g., secretion of hormones, changes in metabolism, or gene expression). Several types of cell surface receptors have been characterized, with the seven transmembrane G-protein-coupled receptors being among the largest families. These receptors are characterized by having (a) seven transmembrane helices and (b) intracellular sequences that couple to G-protein signaling molecules (Harmar 2001 , Mayo et al. 2003 . Receptors for glucagon, GLP-1, and GLP-2 were first identified in mammals, where they were found to be members of the seven transmembrane G-protein-coupled receptor superfamily (Mayo et al. 2003) . Subsequently, a limited number of glucagon receptors from frogs and fish (Ngan et al. 1999 , Sivarajah et al. 2001 , Chow et al. 2004 ) and GLP-1 receptors from fish (Mojsov 2000 , Yeung et al. 2002 have been characterized. Alignments of members of the superfamily of G-protein receptor sequences have shown that the receptors for glucagon, GLP-1, and GLP-2 fall within the class B family of G-proteincoupled receptors, a class that includes receptors for several other glucagon-like sequences, including secretin, GIP, PACAP, VIP, and GRF (Mayo et al. 2003) . Within the class B receptors, the mammalian receptors for glucagon, GLP-1, and GLP-2 are very closely related to one another, and together with the receptor for GIP they form a monophyletic subfamily within this class (Harmar 2001 , Sivarajah et al. 2001 , Joost and Methner 2002 , Fredriksson et al. 2003 ). It appears reasonable to expect the diversity of receptors and hormones to be directly related. Since there is an intimate association between ligand and receptor, one might expect that new ligand-receptor pairs would evolve from parallel duplication, with subsequent modification of ligand and receptor genes yielding phylogenies that mirror each other. Intriguingly, however, the phylogeny of the receptors for glucagon, GLP-1, GLP-2, and GIP is discordant with the accepted phylogeny of the ligands ( figure 2) . Although the GLP-1 and GLP-2 peptides are more closely related to each other than to glucagon (Irwin et al. 1999) , the phylogeny of mammalian receptors for these peptides indicates that the GLP-1 receptor is more closely related to the glucagon receptor than to the GLP-2 receptor (Sivarajah et al. 2001 ).
To gain a better understanding of the relationships between receptors for proglucagon-derived peptides and insight into evolution of hormone action, my colleagues and I have taken advantage of the availability of draft genome sequences from diverse vertebrate species (e.g., see Ensembl project Web site, www.ensembl.org). Since earlier phylogenetic studies, described above, were limited to only a few mammalian sequences, we wished to determine whether similar phylogenetic conclusions could be reached if a greater diversity of the sequences found in nature were sampled. Would these new sequences suggest alternative gene relationships? Among the Yeung et al. 2002) . Since the sequences for GIP receptors are closely related to the sequences for receptors for proglucagon-derived peptides, we included these in our analysis (Harmar 2001 , Sivarajah et al. 2001 , Joost and Methner 2002 , Fredriksson et al. 2003 . The amino acid sequences of known receptors for proglucagon-derived peptides were used to search the fish, frog, and chicken draft genome sequences. The genomes were searched using the tBLAST algorithm (one version of the basic local alignment search tool; Altschul et al. 1997) , which compares an amino acid sequence (the known receptor sequence) to sequences generated by translating the genome sequences into all possible reading frames. Genomic sequences that encode protein sequences with similarity to the known receptor sequences were downloaded from the genome databases (either www. ensembl.org or www.jgi.doe.gov) for further analysis. The isolated genomic sequences were then used to search a database of known and predicted human protein sequences (www.ncbi. nlm.nih.gov/genome/seq/HsBlast.html) using the algorithm BLASTx (Altschul et al. 1997 ) to confirm that they were more similar to the receptors for glucagon, GLP-1, GLP-2, and GIP than to any other gene sequence. Genomic sequences that were clearly more similar to other receptors (e.g., VIP receptors) were removed from our analysis. To complement our genomic database searches, we also searched expressed sequence tag (EST) databases that are located at the genomic databases listed above and the chicken EST database (see www.chick.umist.ac.uk; Boardman et al. 2002) for DNA sequences that potentially encoded receptors for proglucagon-derived peptides. Expressed sequence tags are partial cDNA sequences derived from large-scale cDNA clone sequencing projects that are designed to identify expressed genes; these projects are an excellent resource for gene discovery (Gerhold and Caskey 1996) . Like the genomic sequence described above, ESTs that showed similarity to receptors for proglucagon-derived peptides were searched against the human protein sequence database to eliminate any sequences that were clearly more closely related to other receptor sequences. These searches resulted in the identification of several sequences from the chicken EST database that were most closely related to receptors for glucagon, GLP-1, GLP-2, or GIP. Overlapping ESTs were aligned and assembled into longer cDNA sequences (Irwin and Wong 2005) .
The genomic structures (i.e., locations of coding regions [exons] and intervening noncoding regions [introns] ) of the glucagon, GLP-1, GLP-2, and GIP receptor genes have been characterized in some mammalian species (Mayo et al. 2003) . The relative locations of introns within the protein-coding region are conserved between these four types of receptors in mammals and therefore probably should be conserved throughout these genes in vertebrates. Within the coding sequence of a gene, introns can be classified on the basis of how they interrupt codons (triplets of bases that code for amino acids). That is, if an intron splits a codon such that the first base is in one exon and the second and third bases are in the next intron, it is classified as a phase I intron. Similarly, if the intron is located between the second and third bases of a codon, it is phase II, and if it is located between codons, it is phase 0 (Patthy 1987) . The structure and coding sequence of genes of potential glucagon, GLP-1, GLP-2, and GIP receptors were predicted from the draft bird, frog, and fish genome sequences. The locations of exons and intervening introns of the receptor genes were identified by searching the genomic sequences for regions that were similar to amino acid sequences of known receptors. The boundaries of coding sequences (i.e., intron-exon boundaries) were established on the basis of rules developed for the identification of splice junction (Mount 1982) and the conservation of position and intron phase with respect to the well-characterized mammalian genes (Irwin and Gong 2003 , Zhou and Irwin 2004 , Irwin and Wong 2005 . For the chicken genes, we took advantage of the partial cDNA sequences that were derived from ESTs to help predict exons and coding regions.
Phylogeny of glucagon receptor-like genes
The genome and EST database searches of fish, frog, and chicken genomes resulted in the identification of 21 sequences that have greater similarity to mammalian glucagon, GLP-1, GLP-2, and GIP receptors than to any other mammalian gene sequence. Of the 21 sequences, one of the zebrafish sequences was identical to the previously reported zebrafish GLP-1 receptor (Mojsov 2000) . A total of four receptor-like genes were predicted from the genomes of each of the three fish and the chicken, while five receptor-like genes were predicted from the X. tropicalis genome. To better understand the relationships between the predicted receptor sequences, and to attempt to identify potential ligands for the receptors, the sequences of the receptors were aligned (using Clustal X; Thompson et al. 1994) and their phylogenetic relationships were determined. Because of the draft nature of the genomes, the lack of ESTs from many of the species, and the low conservation of N-terminal and C-terminal sequences of the receptors, many of our predicted receptor gene sequences are currently incomplete. Fortunately, the lack of N-terminal and C-terminal domains is of little consequence for the phylogenetic analysis, as we largely excluded these regions because of the difficulty of aligning and establishing homology of these regions. Phylogenetic analysis was conducted using the portion of the receptor sequences that could be relatively unambiguously aligned among all the receptor sequences, a region, largely confined to the seven transmembrane domains, that has been used in most previous phylogenetic analyses of the G-protein-coupled receptors (Harmar 2001 , Sivarajah et al. 2001 , Joost and Methner 2002 , Fredriksson et al. 2003 . Initial phylogenetic analysis used sequences of a few other characterized class B receptors (e.g., VIP receptors) and demonstrated that all of our new sequences were more closely related to the mammalian glucagon, GLP-1, GLP-2, or GIP receptors than to any of the other G-proteincoupled receptors. These phylogenetic analyses also identified, and strongly supported, the previously described relationship between the mammalian receptors, with the GLP-2 receptor representing the earliest diverging lineage in this subfamily (figure 2 ; Sivarajah et al. 2001) .
To better resolve the genetic relationships within the glucagon receptor-like subfamily, alignments without the other G-protein-coupled receptors were generated to maximize the amount of sequence data that could be aligned for phylogenetic analysis. The mammalian GLP-2 and closely related receptors from nonmammalian species, which had formed a well-supported monophyletic group in the preliminary analyses, were used as the outgroup (comparison sequence) for the phylogenetic analysis. Phylogenies were generated by both parsimony and distance methods. For parsimony methods, the preferred phylogenetic tree would be one that minimizes the number of mutational steps necessary to account for the diversity of amino acid sequences. The distance approach, which uses the neighbor-joining method, finds a tree that groups sequences such that it minimizes the total lengths of the branches of the tree. Both approaches yielded essentially the same phylogenetic conclusions. As shown in figure 3 , we found that all the newly predicted receptor gene sequences fall into one of four monophyletic groups of receptors. Within each of these four monophyletic groups, one of the four mammalian types of receptors (i.e., glucagon, GLP-1, GLP-2, and GIP receptor) were found (figure 3). We have named each of these four groups on the basis of the ligand that the mammalian receptor binds (figure 3). Within the glucagon, GLP-1, and GLP-2 groups of receptors, the phylogeny of species is consistent with the expected vertebrate phylogeny. With this phylogeny, researchers can begin to ask questions about the origin and evolution of the physiological function of the glucagon-like hormones.
Fish GLP-1 receptors
A genome duplication event has been proposed for the ancestral fish lineage (see above). If this happened, then we should expect that immediately after this duplication, the fish genome would have two copies of the glucagon, GLP-1, GLP-2, and GIP receptor genes. Over time, it should be expected that the duplicate genes might diverge in function, or that one of the two copies would be lost, as it would be redundant. Despite a proposed genome duplication event in the ancestral teleost fish lineage (Amores et al. 1998 , Aparicio 2000 , the three fish genomes searched have exactly the same number of glucagon receptor-like genes as mammals have. When these were examined in a phylogenetic context, only three of the four mammalian classes of receptors were found: glucagon, GLP-2, and GIP receptors. In each of the three fish genomes, a single gene of the GLP-2 receptor type was found, and another of the GIP receptor type (figure 3). In contrast, in all three of the fish genomes, we identified two genes of the glucagon receptor type. The phylogeny also indicated that the pair of glucagon receptor genes is the product of a gene duplication event that occurred before the divergence of the teleost fish, consistent with its being part of a genome duplication event (figure 3). The single-copy GLP-2 and GIP receptors may be the result of loss of one of the two duplicates, possibly because they were redundant. A second unexpected finding was that the phylogenetic analysis failed to identify any characterized or predicted fish receptor gene sequences that were more closely related to GLP-1 receptors than to any other receptors (figure 3). This finding was especially surprising given that GLP-1 receptors had been functionally characterized in both zebrafish and goldfish (Mojsov 2000 , Yeung et al. 2002 , and that the sequences of these receptors have been included in our phylogenetic analysis. The phylogenetic analysis demonstrates that the two characterized fish GLP-1 receptors (Mojsov 2000 , Yeung et al. 2002 are much more closely related to glucagon receptors than to GLP-1 receptors (figure 3).
Evolution of GLP-1 function in fish
The unexpected phylogenetic conclusion that fish GLP-1 receptors are not orthologous to mammalian GLP-1 receptors, but instead are orthologous to mammalian glucagon receptors, even though they bind and are activated by GLP-1, suggests an evolutionary explanation for the different biological activities of GLP-1 in fish and mammals. The differences appear to be due to changes in the function of the receptor for GLP-1 and its downstream signaling (Duguay and Mommsen 1994 , Plisetskaya and Mommsen 1996 , Moon 1998 .
The phylogeny in figure 3 suggests that the fish receptor that binds, and is activated by, GLP-1 evolved from a glucagon receptor rather then being orthologous to the mammalian GLP-1 receptor. I propose that duplication of the glucagon re-ceptor gene on the ancestral fish lineage, possibly as part of a fish genome duplication event (Aparicio 2000) , yielded genes for two glucagon receptors in teleost fish (figure 4). Both glucagon receptors initially had identical expression patterns, binding activity, and function. The presence of two genes for glucagon receptors allowed one to be constrained as a glucagon receptor (i.e., conserved function) while the other receptor gene could evolve a new function. I suggest that one of the pair of glucagon receptors acquired the ability to bind and be activated by GLP-1 (figure 4). In support of this suggestion, it has been found that the goldfish GLP-1 receptor has not completely lost its ability to bind and be activated by glucagon (Chow et al. 2004) . The acquisition of the ability to bind GLP-1 most likely occurred before the radiation of teleost fish, as all examined teleost fish have similar GLP-1-induced biological activities (i.e., as a glucogenolytic hormone) (Duguay and Mommsen 1994 , Plisetskaya and Mommsen 1996 , Moon 1998 . This model predicts that the second glucagon receptors (GR2 in figure 3 ) in the puffer fishes Takifugu and Tetraodon bind and are activated by GLP-1.
Since duplication of the fish glucagon receptor gene, both genes have retained similar tissue-specific expression patterns, with a major site of expression being in the liver. Changes in the relative abundance of expression in the liver and in other tissues may account for some of the more minor and species-specific differences in biological action between glucagon and GLP-1 (Duguay and Mommsen 1994 , Plisetskaya and Mommsen 1996 , Moon 1998 . Investigations into the signaling properties of glucagon and GLP-1 in liver cells have uncovered differences in the induction of some second messengers (e.g., cAMP [cyclic adenosine monophosphate]) from these receptors (Moon 2004) . Differences in biological action of glucagon and GLP-1 may be due to changes in signaling properties of the duplicated receptors, some of which may have evolved more recently and may be more species specific.
The study of the receptors for proglucagon-derived peptides illustrates that the binding specificity of receptors can change, which may explain the discordance between the phylogenies of receptors and ligands (figure 2; Sivarajah et al. 2001) . Genome duplication on the early vertebrate lineage yielded a large number of redundant ligands and receptors that have been allowed to evolve new functions. This examination of the evolution of the proglucagon gene and receptors for the proglucagon-derived peptides shows that despite its ancient origins, ligand-receptor specificity can change. It follows that we cannot necessarily infer ancient evolutionary events by looking only at genes from one species, and that we need to examine a broad diversity of nature to begin to understand the origin and evolution of many of the complex physiologies of vertebrates. 
